Hikma Pharmaceuticals Profile

51.23
USD 1.17  2.23%
90%
0%

Hikma Pharmaceuticals Summary

Hikma Pharmaceuticals PLC (HKMPY) is traded on OTC Market in USA. It is located in 1 New Burlington Place and employs 8,500 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 5.98 B. Hikma Pharmaceuticals PLC classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. This company has 240.64 M outstanding shares. HIKMA PHARM has accumulated about 241 M in cash with 403 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.0.
Check Hikma Pharmaceuticals Probability Of Bankruptcy

Hikma Pharmaceuticals Target Price Odds Analysis

Odds Below 51.23HorizonTargetOdds Above 51.23
77.17%30 days 51.23 22.73%
Based on normal probability distribution, the odds of Hikma Pharmaceuticals to move above current price in 30 days from now is about 22.73% (This Hikma Pharmaceuticals PLC probability density function shows the probability of Hikma Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

Hikma Pharmaceuticals PLC Risk Profiles

Hikma Pharmaceuticals Key Fundamentals

Hikma Pharmaceuticals Against Markets

Hikma Pharmaceuticals Current Ratings

Hikma Pharmaceuticals PLC 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
14 
Chance of
Financial Distress (0 to 100%)
12 
Equity ratings for Hikma Pharmaceuticals PLC are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms. The company was founded in 1978 and is based in London, the United Kingdom. Hikma Pharmaceuticals operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market. It employs 8500 people. more
NameHikma Pharmaceuticals PLC
President and CEO, USAMichael RayaView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address1 New Burlington Place
ExchangeOTC Market
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.hikma.com
Phone44 20 7399 2760
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017

Hikma Pharmaceuticals Directors

Hikma Pharmaceuticals Corporate Directors

Pamela Kirby Non-Executive Independent Director
John Castellani Non-Executive Independent Director
Ali AlHusry Non-Executive Director
Please also check Risk vs Return Analysis. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Search macroaxis.com